Protocol of the randomized control trial: the WiseApp trial for improving health outcomes in PLWH (WiseApp).

ABSTRACT:

Background

Poor adherence to antiretroviral therapy (ART) is one of the primary barriers to viral load suppression. mHealth technology can help overcome challenges with ART adherence. This paper outlines the protocol for the WiseApp randomized control trial. The WiseApp contains real-time medication monitoring linking an electronic pill bottle and fitness tracker to the app, helping persons living with HIV (PLWH) self-manage their medication adherence and improve their overall quality of life. The primary objective of the trial is to test the effect of the WiseApp's medication adherence features on antiretroviral adherence in underserved PLWH in New York City.

Methods

This ongoing study is a two-arm randomized control trial. Participants are randomized 1:1 to the WiseApp int

SUBMITTER: Flynn G 

PROVIDER: S-EPMC7686828 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature